A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition(s):Non-small Cell Lung Cancer; Metastatic Non-small Cell Lung CancerLast Updated:February 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer; Metastatic Non-small Cell Lung CancerLast Updated:February 28, 2024Recruiting
Condition(s):Non-squamous Non-small-cell Lung CancerLast Updated:December 27, 2023Completed
Condition(s):Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell Lung; Carcinoma, ThymicLast Updated:April 11, 2023Active, not recruiting
Condition(s):Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung CancerLast Updated:December 8, 2023Active, not recruiting
Condition(s):Stage II-IIIB(N2) Non-small Cell Lung CancerLast Updated:December 19, 2023Not yet recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:March 15, 2016Unknown status
Condition(s):Non-small Cell Lung CancerLast Updated:December 17, 2020Completed
Condition(s):Non-small Cell Lung CancerLast Updated:April 15, 2016Completed
Condition(s):Non-small Cell Lung CancerLast Updated:July 21, 2021Unknown status
Condition(s):Non Small Cell Lung CancerLast Updated:February 25, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.